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Background: Many aspects of CSF dynamics are poorly understood due to the difficulties involved in quantification
and visualization. In particular, there is debate surrounding the route of CSF drainage. Our aim was to quantify CSF
flow, volume, and drainage route dynamics in vivo in young and aged spontaneously hypertensive rats (SHR) using
a novel contrast-enhanced computed tomography (CT) method.
Methods: ICP was recorded in young (2–5 months) and aged (16 months) SHR. Contrast was administered into the
lateral ventricles bilaterally and sequential CT imaging was used to visualize the entire intracranial CSF system and
CSF drainage routes. A customized contrast decay software module was used to quantify CSF flow at multiple
locations.
Results: ICP was significantly higher in aged rats than in young rats (11.52 ± 2.36 mmHg, versus 7.04 ± 2.89 mmHg,
p = 0.03). Contrast was observed throughout the entire intracranial CSF system and was seen to enter the spinal
canal and cross the cribriform plate into the olfactory mucosa within 9.1 ± 6.1 and 22.2 ± 7.1 minutes, respectively.
No contrast was observed adjacent to the sagittal sinus. There were no significant differences between young and
aged rats in either contrast distribution times or CSF flow rates. Mean flow rates (combined young and aged) were
3.0 ± 1.5 μL/min at the cerebral aqueduct; 3.5 ± 1.4 μL/min at the 3rd ventricle; and 2.8 ± 0.9 μL/min at the 4th
ventricle. Intracranial CSF volumes (and as percentage total brain volume) were 204 ± 97 μL (8.8 ± 4.3%) in the
young and 275 ± 35 μL (10.8 ± 1.9%) in the aged animals (NS).
Conclusions: We have demonstrated a contrast-enhanced CT technique for measuring and visualising CSF dynamics
in vivo. These results indicate substantial drainage of CSF via spinal and olfactory routes, but there was little evidence of
drainage via sagittal sinus arachnoid granulations in either young or aged animals. The data suggests that spinal and
olfactory routes are the primary routes of CSF drainage and that sagittal sinus arachnoid granulations play a
minor role, even in aged rats with higher ICP.
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Cerebrospinal fluid (CSF) dynamics are thought to be
altered in many pathological conditions including hydro-
cephalus [1,2], idiopathic intracranial hypertension [3,4],
intracerebral haemorrhage [5], subarachnoid haemorrhage
[6,7], large hemispheric stroke [8,9], traumatic brain injury
[10], and in the aging brain [11,12]. However, relatively
little is known about the exact mechanisms of changes
in CSF dynamics and drainage in these conditions due
to difficulties in quantification.
The role and location of CSF drainage has been studied
in both animals and humans. Traditional interpretation
has been that most CSF drains into the venous sinuses via
arachnoid granulations [13-15]. The primary site of CSF
reabsorption, however, has become a contentious issue
over the last decade. The importance of the olfactory
perineural pathways and the cervical lymphatics [16-19]
in reabsorbing CSF has been studied in several species,
including humans. Postmortem lymphatic vascular cast-
ing [20-22] and radioactive albumin clearance methods
[17,23-25] have demonstrated the major contribution of
these pathways in CSF drainage. Furthermore, physio-
logical studies by Johnston’s group, suggested that the
arachnoid granulations may only come into play when
intracranial pressure is elevated and that lymphatic
drainage routes may play a major role [26,27], especially
in neonates where arachnoid granulations are sparse
[28]. Both human and animal studies indicate that the
spinal route, either via spinal arachnoid granulations or
via lymphatics around spinal nerve root dural sheaths
may also be important [29-35]. These lymphatic routes
may have important immunological significance [19].
To investigate CSF dynamics and drainage within the
entire rat brain we developed a novel contrast-enhanced
computed tomography (CT) technique to image the rat
CSF system in three-dimensions. One unique feature of
this technique is that the dynamic nature of CSF drainage
can be observed in vivo. We chose to compare young and
aged spontaneously hypertensive rats (SHR) because their
cerebral ventricular volume is thought to increase with
age [36,37], which, in addition to the hypertension, may
affect CSF dynamics. In addition, this effect may also
influence physiological variables such as intracranial
pressure, for example, elevated ICP is seen in some
hydrocephalus patients [1,2]. Using our novel contrast-
enhanced CT method, we hypothesized that the aged
SHRs would have altered CSF dynamics and drainage
and a higher baseline ICP when compared to the young
SHRs.
Methods
All animal experiments were conducted in accordance
with the Australian Code of Practice for the Care and Use
of Animals for Scientific Purposes and were approved byThe University of Newcastle Animal Care and Ethics
Committee. Experiments were performed on two cohorts
of male spontaneously hypertensive rats (SHR) (Animal
Resources Centre, Western Australia). One group weighed
200-360 g, aged 2–5 months (n = 5); the other group
weighed 360-400 g, aged 16 months (n = 5). Due to ethical
constraints, we calculated the sample size required to
detect a difference in baseline ICP between two different
rat strains (Wistar and Long Evans; data previously pub-
lished [38]). Using an alpha of 0.05 and Power of 0.80, a
sample size of 5 animals per group was required to detect
a 4.2 mmHg difference between baseline ICP in the two
rat strains.
Surgery and physiological monitoring
Animals were anaesthetised with isoflurane (5% induction,
2% maintenance) in 50:50%, N2:O2 via a facemask. It has
previously been reported in dogs that isoflurane causes
no significant change in the rate of CSF production [39].
Respiratory rate was regularly monitored and core
temperature was maintained at 37°C via a thermocouple
rectal probe and warming plate for the duration of surgi-
cal anaesthesia. Incision sites were shaved, cleaned and
injected subcutaneously with 2 mg/kg 0.05% Bupivacaine
(Pfizer, Australia). To measure arterial blood pressure under
anaesthetic, a fibreoptic microcatheter (SAMBA Sensors,
Sweden) was briefly inserted into the saphenous branch of
the femoral artery, and a steady state baseline arterial blood
pressure trace was recorded.
Intracranial pressure (ICP) was recorded prior to
scanning using a SAMBA microcatheter as previously
described [40] with minor changes. Briefly, animals were
placed in the ear bars of a custom-built CT-compatible
stereotaxic frame. Hollow poly-ether-ether-ketone (PEEK)
screws (Solid Spot LLC, Santa Clara, CA, USA) of 2 mm
in diameter × 5 mm in length were inserted bilaterally
0.3 mm caudal and 1.5 mm lateral to Bregma. The ICP
probe was inserted into the right screw and an airtight seal
made by surrounding both screws in a biocompatiable
caulking material (Silagum, DMG Dental, Hamburg,
Germany). The probe was removed prior to scanning.
Computed tomography (CT) imaging
Following baseline arterial pressure and ICP measure-
ment, animals remained on the same base plate and
stereotaxic frame, which was positioned on the CT scanner
table. All imaging was performed using a 64-slice clinical
CT scanner (Siemens, Erlangen, Germany) [41,42]. The
CSF imaging protocol was developed specifically for the
current study. Each CT-CSF imaging sequence used
0.6 mm slice thickness with coronal plane image acqui-
sition, and a total of 90 slices captured from the rat nose
to the cervical vertebrae (C2). Two 1 ml syringes and two
PE-10 intraventricular catheters were then preloaded with
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Pharmaceuticals Inc.) in 0.9% saline. This dilution was
chosen to reduce the viscosity and make it closer to that
of CSF. Care was taken to ensure that no air bubbles were
present within the catheters. The catheter tips were
inserted 3.5 mm below the skull into each lateral ventricle
via the bilateral screws used for ICP monitoring, and a
head CT scan performed (baseline scan) to ensure that
catheter tips were positioned within each lateral ventricle.
Using an automated syringe driver (Harvard Apparatus,
Pump 11 Elite, MA, USA), contrast was injected into each
ventricle at 2 μL/min for 10 minutes, with a CT scan
performed every minute from the start of infusion. The
infusion rate of 2 μL/min was chosen to reduce the
possibility of the infusion affecting the CSF production
(rodent CSF production rate previously reported as
2.66-2.84 μL/min [43]). Following the cessation of infu-
sion, serial CT scans were performed every 5 minutes for
60 minutes (Figure 1, an additional movie file shows this
in more detail [see Additional file 1]).
Processing CT images
For each animal, serial CT images were loaded into
MiStar software (Apollo Medical Imaging Technology
Pty Ltd, Melbourne, Australia). Motion correction was
performed, and the resulting images were subtracted
from the baseline non-contrast image.
3D reconstruction of CT images: rat CSF system
A representative 3D reconstruction of the rat CSF system
was created by generating a Maximum Intensity Projection
(MIP).The MIP was loaded into the MiStar fusion 3D
render module. Thresholds were applied to the 3D render
to highlight the CSF system.
Visual inspection of contrast time-course throughout
CSF system
The time taken for injected contrast to reach specific
anatomical landmarks within the CSF system was quanti-
fied in each animal. The anatomical landmarks included
the cerebral aqueduct, 3rd ventricle, 4th ventricle, spinal
canal, basal cisterns and cribriform plate. The contrast
window range was set to 0–250 Hounsfield Units (HU)
for each animal sequence to prevent the false detection of
signal noise at each image time-point. The time taken for
the contrast to reach each landmark was calculated by
analysing each sequential image.
CSF flow rate calculations
Contrast-enhanced CT images were processed using the
MiStar software decay module specifically written for rat
imaging. CSF flow rate measured at the cerebral aqueduct
was used to estimate CSF production. Flow rates were also
calculated elsewhere within the CSF system. A smallregion-of-interest (ROI) with 6 voxels was positioned
within the centre of the aqueduct on the 10 minute
time-point scan (post-infusion). The total change in
Hounsfield Units for voxels within the ROI was plotted
over time, and an exponential decay curve was fitted to
the first five decay data points. The exponential decay
rate constant is directly proportional to flow within the
ROI. This principle was applied to each voxel to gener-
ate the Decay Rate Map, measured in ml/min/100 L
(which was then converted to μl/min/100 ml). The
ROI was then co-registered with the Decay Rate Map
to obtain the flow value. Flow was converted into μl/min
by multiplication with volume (slice thickness × area of
ROI). The process was repeated (with the same fixed ROI)
at the 3rd ventricle and 4th ventricle of each animal.Brain and intracranial CSF volume calculation
Twenty five 0.6 mm coronal CT slices were analysed
slice-by-slice to calculate brain and CSF volume. On each
slice, a threshold of 100 HU was set and ROI software
tools were used to define the area of total brain tissue
(using baseline scans) or contrast-enhanced CSF within
the cranium. On each slice, the volume was calculated as
slice thickness × area of ROI. The combined sum of the
ROI volumes was calculated.Statistics
Statistical tests were performed using GraphPad Prism
Version 6 for Windows (GraphPad Software, USA). Two-
tailed Student’s t-test was used to compare differences in
CSF production rate, and CSF volumes between young
and aged groups. Significance was accepted at the p < 0.05
level. T-tests are also reported for physiological variables
for illustrative purposes, with p-values uncorrected for use
of multiple comparisons. Unless otherwise stated, data is
expressed as mean ± standard deviation (±SD).Results
Physiological variables
Arterial blood pressure (systolic/diastolic) was measured
in 3 young animals and 5 aged animals. Mean arterial
blood pressure was lower in the young versus the aged
animals (94 ± 32 mmHg vs. 160 ± 22 mmHg, p = 0.01).
Intracranial pressure (ICP) was measured in all animals
and traces revealed consistent pulse and respiratory
waveforms. A significantly higher ICP was found in
aged rats, 11.52 ± 2.36 mmHg, versus 7.04 ± 2.89 mmHg
in the younger animals, p = 0.03. Cerebral perfusion
pressure (mean arterial blood pressure - intracranial
pressure) was significantly lower in the young versus
the aged animals (86 ± 32 mmHg vs. 148 ± 20 mmHg,
p = 0.02).
Figure 1 Calculating cerebrospinal fluid flow through the cerebral aqueduct of the rat. Radio-opaque contrast (20 μl) was simultaneously
injected into each lateral ventricle at 2 μl/min for 10 min while plain CT images (0.6 mm slice thickness) were taken over 60 minutes. A small
region-of-interest (ROI) (yellow box, arrow) was positioned within the centre of the aqueduct and the decay rate used to generate flow maps. An
additional movie file shows this in more detail [see Additional file 1].
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CSF was observed to drain into the spinal canal (sub-
arachnoid space) and via the olfactory pathway (through
the cribriform plate), the optic nerves, and the cervical
lymph nodes in all animals (Figure 2, an additional movie
file shows this in more detail [see Additional file 2]).
Contrast-enhanced CSF was observed at the cerebral
aqueduct 3.2 ± 0.8 minutes post-injection in both cohorts.
It was first observed to enter the 3rd ventricle 1.8 ± 0.4 mi-
nutes and 1.6 ± 0.5 minutes post-injection in the youngand aged respectively, the 4th ventricle at 4.4 ± 2.2 minutes
and 3.8 ± 0.8 minutes post-injection, the spinal canal at
11.5 ± 9.1 minutes and 7.2 ± 0.8 minutes post-injection,
and the basal cisterns at 18.5 ± 6.8 minutes and 14.0 ±
4.2 minutes post-injection in the young and the aged re-
spectively (Figure 3). Contrast could be observed leaving
the cranial vault at the cribriform plate 23.8 ± 6.3 minutes
post-injection in the young and 21 ± 8.2 minutes in the
aged (Figure 3). No contrast-enhanced CSF was observed
at the sagittal sinus [Additional file 1].
Figure 2 Cerebrospinal fluid (CSF) system in a rat imaged with contrast-enhanced computed tomography (CT). Images show a 3D
render reconstruction of CT images after 20 μL of radio-opaque contrast was injected into each lateral ventricle via cannulae guided through
hollow screws inserted into the skull. Anatomical landmarks of the CSF system in the rat are based on a stereotaxic rat atlas [61]. Basal cisterns are
not depicted in the rat atlas, but their location at the base of the brain is indicated by presence of contrast enhanced CSF in this location. An
additional movie file shows this in more detail [see Additional file 2].
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CSF flow was able to be quantified at multiple sites within
the ventricular system, but flow quantification in the
extraventricular locations was not possible due to respira-
tory motion artifact (spinal canal) and contrast dilution,Figure 3 Time taken for contrast-enhanced cerebrospinal fluid
to reach major anatomical landmarks within the rat CSF
system. Young (2–5 months); Aged (16 months). Mean ± SD.resulting in reduced signal-to-noise ratio and partial vol-
ume averaging error caused by the extensive surface area
of each drainage route. CSF production rates, as measured
by CSF flow rate at the cerebral aqueduct, were 3.14 ±
2.1 μL/min and 2.79 ± 0.57 μL/min in the young and the
aged, respectively. CSF flow rates were 3.74 ± 1.93 μL/min
and 3.19 ± 0.70 μL/min at the 3rd ventricle and 2.89 ±
0.21 μL/min and 2.70 ± 1.29 μL/min at the 4th ventricle
(Figure 4A- 4C). The total intracranial CSF volume was
204 ± 97 μL in the young and 275 ± 35 μL in the aged
cohort (Figure 4D). None of these values differed signifi-
cantly between the young vs. aged cohorts.
Brain volume
Brain volume was 2157 ± 314 mm3 and 2366 ± 233 mm3
in the young and aged rats, respectively (Figure 5). CSF
volumes (and as percentage of brain volume) were
204 ± 97 μL (8.8 ± 4.3%) in the young and 275 ± 35 μL
(10.8 ± 1.9%) in the aged animals. These values were
not significantly different.
Discussion
This study used young and aged SHRs to demonstrate a
new technique for the measurement of CSF flow, volume
and drainage in vivo. The results of this study suggest
that sagittal sinus arachnoid granulations are not the pri-
mary route of CSF drainage and that CSF is primarily
Figure 4 Cerebrospinal fluid (CSF) dynamics in the rat. (A) Flow rate through the cerebral aqueduct; (B) Flow rate through the 3rd ventricle;
(C) Flow rate through the 4th ventricle; (D) Total intracranial CSF volume, in young (2–5 months) versus aged (16 months) spontaneously
hypertensive rats. Data presented as individual data points with mean ± SD.
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taken for contrast-enhanced CSF to reach each drainage
route did not differ between the young and aged animals.
Our novel CT method also allowed for measurement of
CSF flow and volume and found that there was little dif-
ference between young and aged animals, despite a higher
ICP in the aged animals. This method provides an alterna-
tive avenue for the investigation of the pathophysiological
perturbations occurring in disorders of CSF regulation
and abnormal intracranial pressure.
There is increasing recognition of the importance of
altered CSF and brain interstitial fluid dynamics with
age, not only in conditions such as normal pressure
hydrocephalus but also in dementias such as Alzheimer’sFigure 5 Total brain volume calculated from baseline non-contrast
images. Young (2–5 months); Aged (16 months). Mean ± SD.disease [44,45]. Despite this, most CSF-related research
occurs in young animals. In the current study we investi-
gated CSF dynamics in an aged population of SHRs, since
this strain is known to develop hypertension, ventriculo-
megaly and cerebral volume loss with age [36,37]. We
found little difference in the absolute CSF flow rates or
total brain volume between young (2–5 months) and aged
(16 months) rats. These data are similar to findings in a
previous study of normotensive rats (without ventriculo-
megaly) aged from 3–30 months. Chiu et al. found that
peak CSF production occurs at 10 months before steadily
decreasing over time to almost baseline values [43].
Furthermore, the values they reported in 12–20 month
rats ranged from 2.66-2.84 μL/min, which were compar-
able to our reported values in 16 month aged rats and to
previously reported values in 3–4 months old rats in other
studies [46,47]. It is also interesting to note that the CSF
flow rates, when measured at different anatomical loca-
tions within the CSF ventricular system, did not vary
greatly. The lack of a significant difference in in vivo CSF
volumes between young and aged SHRs is inconsistent
with previous in vitro studies, and most likely due to a
lack of statistical power to detect a difference in this vari-
able. This was contributed to by small animal numbers
and in particular by the significant between-animal vari-
ability in the younger cohort. The point estimate of a 26%
difference is in keeping with previous published data
[36,37]. Additionally, it may be that changes would be
more apparent in ‘elderly’ (≈2 years) animals, than in at
16 months of age. This age was chosen to avoid the
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this strain. Our data also demonstrated a significantly
higher intracranial pressure (ICP) and cerebral perfusion
pressure (CPP) in the aged rats when compared to the
young. This is consistent with findings in humans [48,49]
and in other rat strains [50]. Additionally, the greater vari-
ability in CPP in the young animals may have contributed
to the greater variance in CSF data, i.e. there was a greater
percentage of variance (relative to the mean) in mean
arterial pressure, and in ICP, in the young vs. aged. It is
plausible that greater variance in CPP resulted in greater
variance in CSF flow and drainage parameters, as changes
in CPP may affect CSF production and drainage.
Although the ICP was higher in aged animals, we
could not see any contrast adjacent to or filling the sa-
gittal sinus to indicate drainage of the CSF via arachnoid
granulations, even at the later time points. There was,
however, clear evidence of passage of contrast into the
spinal canal, olfactory cavity, along the ophthalmic nerves
and into cervical lymph nodes. Our findings support
recent studies that the primary route of CSF drainage in
most mammalian species is via perineural sheaths. In ana-
tomical studies using a coloured tracer and anatomical
dissection, CSF drainage into nasal lymphatics via the
olfactory nerves and cribriform plate has been demon-
strated in sheep, pigs, rabbits, rats, mice and monkeys
[16,17,20-25]. Additionally presence of this route has
been shown in human cadavers [20]. Many studies
have also demonstrated spinal lymphatic CSF drainage
using tracers in several mammalian species including
humans [22,23,26,35,51]. It was calculated that the rate
of spinal CSF absorption was between 38–76% of CSF
production in healthy individuals (higher during activity)
[35]. At least in the sheep, the venous sinus arachnoid
granulation pathway of CSF absorption appears to be a
secondary pathway only recruited at high intracranial
pressures, for example after a neurological injury [17,28].
The calculation of CSF volume is technically challenging
and many techniques have been tried, with varying
success. Values obtained in this study correspond well
to some published data in rats using quite different
techniques, including volumes of 233–240 μL in young
SHRs using the ventriculo-cisternal dilution method
[46,47] and volumes from 275–441 μL in Fischer 344/BN
rats using magnetic resonance imaging [43]. However,
some published studies report much higher volumes.
Lai et al. (1983) reported a mean CSF volume of 580 μL
in rats using the formula ‘CSF volume = CSF formation
rate/CSF turnover rate’ [52]. They assumed that the CSF
turnover rate was constant amongst species [53], and used
the human CSF turnover rate of 0.38% per minute (ob-
tained using ventriculo-lumbar perfusion method from
12 children with subacute sclerosing panencephalitis
and pontine glioma) [54], to calculate CSF volume. Weare not sure that this assumption is well justified. However,
despite these potential limitations, the rat CSF volume and
turnover rate from that paper appear to have become the
accepted values in reviews of the field, perhaps due to the
paucity of other available data [55-57].
Our novel CT method provides several possible advan-
tages, and some limitations, when compared with other
techniques such as the ventriculo-cisternal dilution and
post-mortem dye-tracer methods. First among these is
that it does not require an intracisternal draining catheter,
with potential resultant effects on ICP and possibly on
CSF production, if homeostatic mechanisms are evoked.
Secondly, the ability to image the entire CSF system sim-
ultaneously and sequentially gives a more complete under-
standing of the dynamics of CSF flow and drainage. We
were able to monitor the major physiological parameters
thought to influence CSF production rate, that is, ICP
[58], blood pressure [59], and temperature [60]. Addition-
ally, flow rates, whole brain volume, and CSF volume
calculations were obtained from the same study. Some
unavoidable limitations also exist with the CT method,
and particular points of the analysis require great care.
In particular, partial volume averaging effects are a
known potential problem when measuring values from
a very small structure such as the cerebral aqueduct.
Great care must be taken to identify the midpoint of the
region of contrast enhancement for placement of a
small region-of-interest. An additional limitation is that
although we could observe and quantify the time taken
for contrast-enhanced CSF to reach the drainage path-
ways in vivo, we have been unable to reliably quantify
the volume of CSF draining via these routes.
Conclusions
We have provided in vivo data using CT imaging of CSF
distribution over time, which indicates that the primary
route of CSF drainage in young and aged rats is via the
spinal and olfactory lymphatics, and that drainage into
the sagittal sinus arachnoid granulations plays at most a
minor role. The CT technique we developed provides an
alternative to ventriculo-cisternal dilution methods for
measurement of CSF flow through the cerebral aqueduct,
the widely accepted surrogate measure for CSF produc-
tion. It avoids the need to puncture the cisterna magna
and permits visualisation and timing of CSF distribution
and drainage, quantification of CSF flow elsewhere within
the ventricular system and measurement of total brain
and intracranial CSF volumes. Interestingly, this study of
young and aged SHRs suggest that CSF production rates
and volumes are quite similar, and do not change dramat-
ically with age. The information gathered using our novel
contrast-enhanced CT method may provide much needed
insight into the CSF dynamics and drainage involved in
many neurological diseases.
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Additional file 1: Contrast-enhanced cerebrospinal fluid flow
through the cranium over 60 minutes. Radio-opaque contrast (20 μl)
was simultaneously injected into each lateral ventricle at 2 μl/min for
10 min while plain CT images (0.6 mm slice thickness) were taken over
60 minutes. File format: mov.
Additional file 2: 3D render reconstruction of cerebrospinal fluid
system of the rat. The computed tomography images of one rat were
loaded in MiStar software and subtracted from the baseline non-contrast
image. A Maximum Instensity Projection was generation and loaded into
the MiStar fusion 3D render module. File format: mov.
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